WILLIAM WONG to Carbazoles
This is a "connection" page, showing publications WILLIAM WONG has written about Carbazoles.
Connection Strength
0.231
-
Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada. Curr Oncol. 2024 Dec 27; 32(1).
Score: 0.231